The Nasdaq Hearings Panel has granted the company’s request for continued listing on The Nasdaq Capital Market pursuant to an extension through April 15, 2024.
The Ohio Division of Cannabis Control will accept comments through Feb. 9 on changes to the medical cannabis program and draft rules for the state’s forthcoming adult-use market.